Adaptive Biotechnologies Corporation (ADPT): Price and Financial Metrics

Adaptive Biotechnologies Corporation (ADPT): $4.42

0.06 (-1.34%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add ADPT to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#59 of NR

in industry

ADPT Price/Volume Stats

Current price $4.42 52-week high $6.70
Prev. close $4.48 52-week low $2.28
Day low $4.33 Volume 1,819,500
Day high $4.57 Avg. volume 1,409,832
50-day MA $4.96 Dividend yield N/A
200-day MA $3.99 Market Cap 652.30M

ADPT Stock Price Chart Interactive Chart >


Adaptive Biotechnologies Corporation (ADPT) Company Bio


Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.


ADPT Latest News Stream


Event/Time News Detail
Loading, please wait...

ADPT Latest Social Stream


Loading social stream, please wait...

View Full ADPT Social Stream

ADPT Price Returns

1-mo -5.96%
3-mo -9.05%
6-mo 28.49%
1-year 4.00%
3-year -83.23%
5-year -84.57%
YTD -9.80%
2023 -35.86%
2022 -72.77%
2021 -52.55%
2020 97.63%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!